Pfizer reportedly will seek FDA approval for a second vaccine booster for people 65 and older

According to the Washington Post, Pfizer and BioNTech are expected to seek emergency authorization for a second booster shot of the coronaviruses vaccine for those 65 and older.

The FDA could make a submission as early as Tuesday, according to the Post. The submission is expected to include real-life data from Israel, one of the only countries that has authorized a second booster shot, according to sources close to the situation.

Pfizer CEO Albert Bourla said in an interview with CBS that a second coronaviruses booster shot is necessary because of the protection against COVID-19.

It is necessary to have a fourth booster right now, Bourla said.

It doesn't last very long against infections. We will submit the data to the FDA and see what the experts say.

The FDA approval could come fairly quickly, depending on how straightforward Pfizer's data is, the Post reported.